Department of Electrical and Electronic Engineering, The University of Melbourne, Melbourne, VIC 3010, Australia.
Physiol Meas. 2018 Nov 1;39(10):105013. doi: 10.1088/1361-6579/aae305.
Non-invasive fetal electrocardiography (NI-FECG) shows promise for capturing novel physiological information that may indicate signs of fetal distress. However, significant deterioration in NI-FECG signal quality occurs during the presence of a highly non-conductive layer known as vernix caseosa which forms on the fetal body surface beginning in approximately the 28th week of gestation. This work investigates asymmetric modeling of vernix caseosa and other maternal-fetal tissues in accordance with clinical observations and assesses their impacts for NI-FECG signal processing.
We develop a process for simulating dynamic maternal-fetal abdominal ECG mixtures using a synthetic cardiac source model embedded in a finite element volume conductor. Using this process, changes in NI-FECG signal morphology are assessed in an extensive set of finite element models including spatially variable distributions of vernix caseosa.
Our simulations show that volume conductor asymmetry can result in over 70% error in the observed T/QRS ratio and significant changes to signal morphology compared to a homogeneous volume conductor model. Volume conductor effects must be considered when analyzing T/QRS ratios obtained via NI-FECG and should be considered in future algorithm benchmarks using simulated data.
This work shows that without knowledge of the influence of volume conductor effects, clinical evaluation of the T/QRS ratio derived via NI-FECG should be avoided.
非侵入式胎儿心电图(NI-FECG)有望捕捉到可能表明胎儿窘迫迹象的新生理信息。然而,在大约妊娠 28 周开始形成于胎儿体表的高度非传导性胎脂层的存在下,NI-FECG 信号质量会显著恶化。这项工作根据临床观察对胎脂层和其他母体-胎儿组织进行非对称建模,并评估它们对 NI-FECG 信号处理的影响。
我们开发了一种使用嵌入在有限元容积导体中的合成心脏源模型来模拟动态母体-胎儿腹部 ECG 混合物的过程。使用该过程,在包括胎脂层空间变化分布的广泛有限元模型中评估了 NI-FECG 信号形态的变化。
我们的模拟表明,与均匀容积导体模型相比,容积导体的非对称性会导致观察到的 T/QRS 比值出现超过 70%的误差,并且信号形态发生显著变化。在分析通过 NI-FECG 获得的 T/QRS 比值时,必须考虑容积导体效应,并且应该在使用模拟数据的未来算法基准测试中考虑它们。
这项工作表明,如果不知道容积导体效应的影响,应避免通过 NI-FECG 对 T/QRS 比值进行临床评估。